• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Ellington Financial Buys Two Mortgage REITs Within Two Months

    7/6/23 4:22:45 PM ET
    $AAIC
    $AJX
    $CRON
    $EFC
    Real Estate Investment Trusts
    Real Estate
    Real Estate Investment Trusts
    Real Estate
    Get the next $AAIC alert in real time by email

    Mergers on Wall Street have a way of creating substantial volatility. 

    Usually, the company that makes the acquisition immediately loses a few points, while the company that is acquired skyrockets because of the price premium it receives on the deal. Investors who own the acquiring company hope that the merger will create substantial earnings and revenue that will propel the stock higher down the road.

    But it doesn’t always work out that way. One well-known example of a deal that went south was tobacco giant Altria Group Inc. (NYSE:MO), acquiring 35% of private company Juul Labs Inc. and a 45% stake in Cronos Group Inc. (NASDAQ:CRON). Altria lost over $1 billion on Juul, and Cronos shares are down about 86% since Altria’s purchase in December 2018.

    Take a look at one mortgage real estate investment trust (mREIT) that recently purchased two other mREITs over the past two months and whether it appears that investors should be optimistic about the purchases.

    Ellington Financial Inc. (NYSE:EFC) is an Old Greenwich, Connecticut-based mREIT that invests in a diverse number of financial assets, including residential and commercial mortgage loans, residential and commercial mortgage-backed securities, consumer loans, collateralized loan obligations, nonmortgage- and mortgage-related derivatives and other strategic debt and equity investments. 

    Ellington Financial takes some risks other mREITs won’t touch, but only if it feels the return adequately compensates for that risk. For example, loans are often made to underserved niche market segments that cannot procure loans elsewhere. Ellington Financial uses a risk-management infrastructure system to assess the risks involved in any deals it makes and charges higher interest rates to compensate for potential losses.

    Ellington Financial has done well over the first half of 2023, with a total return of 16.95%. It has a market cap of $919.645 million.

    On May 30, Ellington Financial announced it was entering into a definitive merger agreement with Arlington Asset Investment Corp. (NYSE:AAIC), a McLean, Virginia-based mREIT that invests in mortgage-related assets and residential real estate. It divides its capital between agency mortgage-backed securities, mortgage servicing right-related assets, credit investments and single-family residential properties.

    Under the terms of the agreement, Ellington Financial will pay $4.77 per Arlington common stock share. This was a 73% premium to the closing price on May 26 for Arlington Asset Investment and a 15% discount to Arlington’s diluted tangible book value per share as of March 31.

    Arlington Asset Investment has a poor record over the past five years. Its quarterly earnings per share (EPS), which ranged between $0.44 and $0.59 in 2018, have declined into the single digits. Its total return over the past five years is negative 38.33%. It also suspended its dividend at the end of 2019 and has not paid one since.

    Arlington Asset Investment’s total return of 56.95% in the first half of 2023 is far better, but most of that was the direct result of the merger announcement. Bethe announcement, Arlington Asset had a first half 2023 total return of negative 6.78% in the first half of 2023. 

    Then on July 3, Ellington Financial announced it will acquire Great Ajax Corp. (NYSE:AJX) for $7.33 per share, a 19.5% premium to the $6.13 closing price of Great Ajax on June 30. At the close of the transaction, each Great Ajax common share will convert to 0.5308 shares of Ellington Financial stock.

    “We are extremely excited about the opportunity to add a significant portfolio of strategic assets, including over $1 billion of highly creditworthy first-lien residential RPL (reperforming loans) and NPL (nonperforming loans) investments at attractive prices, which complement our existing investment portfolio nicely and align with our expertise and existing management platform,” Ellington Financial CEO Laurence Penn said of the purchase.

    Ellington Financial makes it clear that its philosophy is to assess risk before making any transaction, and there are risks to these acquisitions. On May 5, Great Ajax cut its quarterly dividend from $0.25 to $0.20, following its poor earnings report the previous day. Non-generally accepted accounting practices (GAAP) earnings per share of negative $0.09 missed analyst estimates by $0.14, and revenue of $0.54 million was $6.3 million below the estimates.

    Great Ajax purchases inferior-quality single-family mortgage loans and gets them to perform better, but that is a strategy that works best in an economic recovery, and if the U.S. goes into recession, that could be a long way off. When one of its loans goes into foreclosure, it takes back the property and either sells or rents it out. Great Ajax also purchases high-risk re-performing mortgages (loans where the borrower has missed payments before but is now current) at a discount.

    Since the beginning of 2022, Great Ajax has had a negative total return of 35.83%, but in 2023, the shares have performed a bit better with a 1% total return.

    Analysts have been bullish on Ellington Financial recently. On May 16, Keefe, Bruyette & Woods Inc. upgraded Ellington Financial from Market Perform to Outperform and announced a price target of $13.75. On May 26, JMP Securities reiterated a Market Outperform rating on Ellington Financial and maintained a $13.50 price target.

    Long-term Ellington Financial investors will hope that these two acquisitions bear fruit in the years to come, but for now it looks like Ellington Financial has taken on two new and somewhat large risks in its overall portfolio.

    Weekly REIT Report: REITs are one of the most misunderstood investment options, making it difficult for investors to spot incredible opportunities until it’s too late. Benzinga’s in-house real estate research team has been working hard to identify the greatest opportunities in today’s market, which you can gain access to for free by signing up for Benzinga’s Weekly REIT Report.

    Read next:

    • Bezos-Backed Startup Lets You Become A Landlord With $100
    • Elon Musk Is Bullish On Austin. Here's How To Invest In The City's Growth Before He Floods It With New Tech Workers
    Get the next $AAIC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAIC
    $AJX
    $CRON
    $EFC

    CompanyDatePrice TargetRatingAnalyst
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Altria Group Inc.
    $MO
    1/9/2026$63.00Neutral → Buy
    UBS
    Altria Group Inc.
    $MO
    7/9/2025$50.00Underperform
    Jefferies
    Altria Group Inc.
    $MO
    7/2/2025$59.00Sell → Neutral
    UBS
    Altria Group Inc.
    $MO
    4/1/2025Buy → Hold
    Deutsche Bank
    Altria Group Inc.
    $MO
    1/16/2025$54.00Equal-Weight
    Morgan Stanley
    Altria Group Inc.
    $MO
    12/6/2024$55.00 → $65.00Neutral → Buy
    BofA Securities
    Altria Group Inc.
    $MO
    10/8/2024$44.50 → $48.00Neutral
    Citigroup
    More analyst ratings

    $AAIC
    $AJX
    $CRON
    $EFC
    SEC Filings

    View All

    Ellington Financial Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Ellington Financial Inc. (0001411342) (Filer)

    2/9/26 4:52:28 PM ET
    $EFC
    Real Estate
    Finance

    Altria Group Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:20:21 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits

    8-K - ALTRIA GROUP, INC. (0000764180) (Filer)

    1/29/26 7:04:06 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $AAIC
    $AJX
    $CRON
    $EFC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Ellington Financial Announces Release Date of Fourth Quarter 2025 Earnings, Conference Call, and Investor Presentation

    Ellington Financial Inc. (NYSE:EFC) (the "Company") today announced that it will release financial results for the quarter ended December 31, 2025 after market close on Wednesday, February 25, 2026. The Company will host a conference call to discuss its financial results at 11:00 a.m. Eastern Time on Thursday, February 26, 2026. To participate in the event by telephone, please dial (800) 343-4136 at least 10 minutes prior to the start time and reference the conference code EFCQ425. International callers should dial (203) 518-9843 and reference the same code. The conference call also will be webcast live and can be accessed via the "For Investors" section of the Company's website at www.elli

    2/11/26 4:20:00 PM ET
    $EFC
    Real Estate
    Finance

    Ellington Financial Declares Monthly Common Dividend

    Ellington Financial Inc. (NYSE:EFC) ("we") today announced that its Board of Directors has declared a monthly dividend of $0.13 per share of common stock, payable on March 31, 2026 to common stockholders of record as of February 27, 2026. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as p

    2/9/26 4:19:00 PM ET
    $EFC
    Real Estate
    Finance

    $AAIC
    $AJX
    $CRON
    $EFC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Ronald I was granted 9,198 shares and bought $75,176 worth of shares (5,544 units at $13.56) (SEC Form 4)

    4 - Ellington Financial Inc. (0001411342) (Issuer)

    10/2/25 4:33:02 PM ET
    $EFC
    Real Estate
    Finance

    Davis Robert Matthews bought $48,599 worth of shares (1,200 units at $40.50), increasing direct ownership by 16% to 8,473 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:08:44 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Clarke Ian L.T. bought $44,625 worth of shares (1,100 units at $40.57), increasing direct ownership by 18% to 7,145 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    11/8/23 3:03:21 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $AAIC
    $AJX
    $CRON
    $EFC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria upgraded by UBS with a new price target

    UBS upgraded Altria from Neutral to Buy and set a new price target of $63.00

    1/9/26 8:23:08 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Jefferies resumed coverage on Altria with a new price target

    Jefferies resumed coverage of Altria with a rating of Underperform and set a new price target of $50.00

    7/9/25 8:26:04 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    $AAIC
    $AJX
    $CRON
    $EFC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gifford William F. Jr. gifted 15,700 shares, decreasing direct ownership by 2% to 673,427 units (SEC Form 4)

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    2/6/26 2:55:27 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 4 filed by Director Munoz George

    4 - ALTRIA GROUP, INC. (0000764180) (Issuer)

    1/20/26 5:03:46 PM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Mumford Lisa was granted 7,657 shares, increasing direct ownership by 9% to 88,773 units (SEC Form 4)

    4 - Ellington Financial Inc. (0001411342) (Issuer)

    1/5/26 4:36:36 PM ET
    $EFC
    Real Estate
    Finance

    $AAIC
    $AJX
    $CRON
    $EFC
    Leadership Updates

    Live Leadership Updates

    View All

    Altria Group, Inc. Announces Retirement of CEO Billy Gifford and Appointment of Sal Mancuso as Successor

    Altria Group, Inc. (Altria) (NYSE:MO) announces today that Billy Gifford, Altria's Chief Executive Officer (CEO), has decided to retire, effective May 14, 2026 at the conclusion of the 2026 Annual Meeting of Shareholders (2026 Annual Meeting). Billy has had a distinguished career of over 30 years with the Altria family of companies and has served as Altria's CEO since 2020. Altria's Board of Directors (Board) has elected Salvatore (Sal) Mancuso to serve as Altria's CEO upon Billy's retirement. To facilitate a smooth transition, Billy plans to serve as a consultant to Altria upon his retirement through at least the end of 2026. Additionally, the Board elected Heather Newman to serve as Altri

    12/11/25 7:00:00 AM ET
    $MO
    Medicinal Chemicals and Botanical Products
    Health Care

    Altria Group, Inc. Announces Retirement of Director George Muñoz from Board of Directors

    Altria Group, Inc. (Altria) (NYSE:MO) -- George Muñoz, a director of Altria since 2004, notified Altria of his decision to retire from service on our Board of Directors (Board) following the completion of his current term. Consequently, Mr. Muñoz will not stand for re-election to our Board at our 2026 Annual Meeting of Shareholders, which Altria anticipates holding on May 14, 2026. "George has made extensive and significant contributions to Altria over more than 20 years," said Kathryn McQuade, Altria's independent Chair of the Board. "We thank George for his long-standing and valuable service and wish him the very best upon his retirement." Mr. Muñoz is Chair of the Compensation and Ta

    10/9/25 8:35:00 AM ET
    $LAUR
    $MO
    Other Consumer Services
    Real Estate
    Medicinal Chemicals and Botanical Products
    Health Care

    Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

    TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the "Meeting"), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company's definitive proxy statement dated April 25, 2025 was elected as a director of the Company, with each director receiving in excess of 92.3% of the votes cast in favor of his or her election. The detailed results of the vote for the e

    6/23/25 5:30:00 PM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    $AAIC
    $AJX
    $CRON
    $EFC
    Financials

    Live finance-specific insights

    View All

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Ellington Financial Announces Release Date of Fourth Quarter 2025 Earnings, Conference Call, and Investor Presentation

    Ellington Financial Inc. (NYSE:EFC) (the "Company") today announced that it will release financial results for the quarter ended December 31, 2025 after market close on Wednesday, February 25, 2026. The Company will host a conference call to discuss its financial results at 11:00 a.m. Eastern Time on Thursday, February 26, 2026. To participate in the event by telephone, please dial (800) 343-4136 at least 10 minutes prior to the start time and reference the conference code EFCQ425. International callers should dial (203) 518-9843 and reference the same code. The conference call also will be webcast live and can be accessed via the "For Investors" section of the Company's website at www.elli

    2/11/26 4:20:00 PM ET
    $EFC
    Real Estate
    Finance

    Ellington Financial Declares Monthly Common Dividend

    Ellington Financial Inc. (NYSE:EFC) ("we") today announced that its Board of Directors has declared a monthly dividend of $0.13 per share of common stock, payable on March 31, 2026 to common stockholders of record as of February 27, 2026. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve numerous risks and uncertainties. Our actual results may differ from its beliefs, expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as p

    2/9/26 4:19:00 PM ET
    $EFC
    Real Estate
    Finance

    $AAIC
    $AJX
    $CRON
    $EFC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Great Ajax Corp.

    SC 13G/A - Great Ajax Corp. (0001614806) (Subject)

    11/13/24 4:20:08 PM ET
    $AJX
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Great Ajax Corp.

    SC 13G/A - Great Ajax Corp. (0001614806) (Subject)

    11/8/24 12:59:51 PM ET
    $AJX
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Great Ajax Corp.

    SC 13G/A - Great Ajax Corp. (0001614806) (Subject)

    11/8/24 10:41:07 AM ET
    $AJX
    Real Estate Investment Trusts
    Real Estate